Improving medical students

Cosmetic Eyelash Drug Approved

Posted by medliorator on January 16, 2009

The Food and Drug Administration (FDA) has green-lighted Latisse, which lengthens, thickens and darkens eyelashes when dabbed daily on the lash line on the lids with a disposable wand.

The med, called Latisse, should be available by March from a doctor or with a prescription from one. Price tag: $120 for a month’s supply.

The active ingredient in Latisse is bimatoprost, a compound derived from fatty acids that bind to receptors in the eyelashes that may be involved in the development and re-growth of hair follicles. Allergan has used bimatoprost since 2001 in Lumigan, an Rx eye drop that lowers eye pressure in people with glaucoma.

Latisse: New eyelash-lengthening drug approved [Scientific American]


2 Responses to “Cosmetic Eyelash Drug Approved”

  1. Nicole said

    How is this different from RevitaLash, a drug thats been out for about 2 years and does the same thing? Is RL not FDA approved?

    • medliorator said

      Bimatoprost (Latisse) was approved for cosmetic use by the FDA in Dec 2008. Its use for glaucoma was originally approved in 2001. I was unable to find the name of RevitaLash’s active ingredient (, nor was I able to spot any mention of FDA approval (or clinical research for that matter). RevitaLash did not produce any search results at the FDA drug database website. My assumptions are:
      -RevitaLash is NOT approved by the FDA
      -RevitaLash is one of countless cosmetic products sold for purported lash enhancement (competitors = Marini, LashGro, Mavala, Ardell, Procyte, etc.)
      -Aside from testimonial, data regarding the adverse effects (let alone efficacy) of RevitaLash in literature appear to be nonexistent.

Sorry, the comment form is closed at this time.

%d bloggers like this: